Details for 2019157227
Up to date per 04.04.2026
Actions
Details for 2019157227
Granted/Registered
European Patent
10.07.2019 A
11.02.2026 B1
23.08.2013
US
201361869596 P
05.11.2013
US
201361900283 P
20.05.2014
US
201462000946 P
A61K 31/519 20060101AFI20190527BHEP
Owner
Neupharma, Inc.1175 Chess Drive Suite 206 Foster City, CA 94404US
Representative
No representatives present
Inventor
QIAN, Xiangping114 Mira Street Foster City, CA 94404US
ZHU, Yong-Liang41077 Pementel Court Fremont, CA 94539US
Information about Fees